Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4212.00 | 3928.50 | 1.0722 | 1.1336 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1928.00 | 3928.50 | 0.4908 | 0.0332 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4136.00 | 3928.50 | 1.0528 | 1.0978 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3949.00 | 3928.50 | 1.0052 | 1.0097 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 4153.00 | 3928.50 | 1.0571 | 1.1058 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 2200.00 | 3928.50 | 0.5600 | 0.1678 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 3887.00 | 3928.50 | 0.9894 | 0.9804 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1325.00 | 3928.50 | 0.3373 | -0.2705 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4032.00 | 3928.50 | 1.0263 | 1.0489 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3980.00 | 3928.50 | 1.0131 | 1.0243 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 3898.00 | 3928.50 | 0.9922 | 0.9856 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3908.00 | 3928.50 | 0.9948 | 0.9903 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3635.00 | 3928.50 | 0.9253 | 0.8610 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3634.00 | 3928.50 | 0.9250 | 0.8605 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3140.00 | 3928.50 | 0.7993 | 0.6246 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1547.00 | 3928.50 | 0.3938 | -0.1577 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2808.00 | 3928.50 | 0.7148 | 0.4646 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3907.00 | 3928.50 | 0.9945 | 0.9898 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 3746.00 | 3928.50 | 0.9535 | 0.9136 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3112.00 | 3928.50 | 0.7922 | 0.6111 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2087.00 | 3928.50 | 0.5313 | 0.1120 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 2031.00 | 3928.50 | 0.5170 | 0.0843 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4166.00 | 3928.50 | 1.0605 | 1.1120 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 3817.00 | 3928.50 | 0.9716 | 0.9473 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1861.36 | 3662.00 | 3928.50 | 0.9322 | 0.8738 |